Rocuronium

InformationBranaplam (LMI070) Branaplam (LMI070) is a highly selective, small-molecule splicing modulators of survival motor neuron‑2 (SMN2) with an EC50 of 0.02 μM.TargetsSMN2 0.02 μM(EC50).

This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034 . This CRM is traceable to primary material from an NMI, e.

MK-0493 is a potent, orally active and selective agonist of the melanocortin receptor 4 (MC4R) , demonstrating significant reductions in energy intakeIn VivoMK-0493 dose-dependently increases electrically evoked increases in ICP. MK-0493 is shown to

A potent, reversible inhibitor of &gamma-secretase, reducing the cleavage of APP to A&beta40 in SH-SY5Y cells with an IC₅₀ value of 5 nM orally bioavailable and crosses the blood-brain barrier, as orally administered MK-0752

Biochem/physiol Actions MKC-733 is a 5-HT 3 specific agonist. Features and Benefits This compound is a featured product for Neuroscience research.

neuromedin U-25.

Neuron Model, 2 Part

ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.

ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.

ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.

ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.

InformationRocuronium Bromide Rocuronium Bromide (ORG 9426) is a competitive AchR antagonist, used in modern anaesthesia.In vitroRocuronium bromide (RB), an aminosteroid type neuromuscular blocking agent, acts by reducing or inhibiting the